Nobiletin improves diphenoxylate-induced constipation and the accompanied depressive behavior disorders by regulating gut-SCFAs-brain axis

This publication has 50 references indexed in Scilit:

• Constipation preceding depression: a population-based cohort study
  eClinicalMedicine, 2024
• Beneficial effects of nobiletin on regulation of lipid metabolism
  Food Bioscience, 2023
• Neuroprotective effects of short-chain fatty acids in MPTP induced mice model of Parkinson's disease
  Experimental Gerontology, 2021
• Extraction optimization and constipation-relieving activity of dietary fiber from Auricularia polytricha
  Food Bioscience, 2020
• Paricalcitol alleviates lipopolysaccharide-induced depressive-like behavior by suppressing hypothalamic microglia activation and neuroinflammation
  Biochemical Pharmacology, 2019
• Acrylamide aggravates cognitive deficits at night period via the gut–brain axis by reprogramming the brain circadian clock
  Archives of Toxicology, 2018
• Expert consensus on the assessment and treatment of chronic constipation in the elderly
  Aging Medicine, 2018
• The impact of severe mental disorders and psychotropic medications on sexual health and its implications for clinical management
  World Psychiatry, 2018
• Nobiletin protects against cerebral ischemia via activating the p-Akt, p-CREB, BDNF and Bcl-2 pathway and ameliorating BBB permeability in rat
  Brain Research Bulletin, 2013
• Imipramine treatment increases the number of hippocampal synapses and neurons in a genetic animal model of depression
  Hippocampus, 2010